RGNT · Regentis Biomaterials Ltd. · Documents
Market Cap
$13.91M
Shares
7.02M
Volume · Oct 6
33.97K
Avg daily vol (3M)
77.18K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-09-11 | 2026-06-30 | |
| 6-K | 2026-07-20 | — | |
| 6-K | 2026-07-15 | — | |
| 6-K | 2026-07-09 | — | |
| 6-K | 2026-07-02 | — | |
| 6-K | 2026-06-18 | — | |
| 6-K | 2026-06-15 | — | |
| 6-K | 2026-06-08 | — | |
| 6-K/A | 2026-06-04 | — | |
| 6-K | 2026-05-28 | — | |
| 20-F/A | 2026-02-27 | 2025-12-31 | |
| 20-F | 2026-02-24 | 2025-12-31 | |
| 6-K | 2026-02-24 | — | |
| 6-K | 2026-02-17 | — | |
| 6-K | 2026-02-05 | — | |
| 6-K | 2026-01-29 | — | |
| 6-K | 2026-01-20 | — | |
| 6-K | 2026-01-06 | — | |
| 6-K | 2026-01-06 | — | |
| 6-K | 2025-12-18 | — | |
| 6-K | 2025-12-05 | — |
Showing 1–21 of 21 filings